Directors Dealings

SCYNEXIS Inc

CEO Angulo Buys $100 M‑Deal Shares Ahead of SCYNEXIS Private Placement—Signal of Confidence Amid Volatility

CEO Angulo Buys $100 M‑Deal Shares Ahead of SCYNEXIS Private Placement—Signal of Confidence Amid Volatility

CEO buys SCYNEXIS shares amid $100 M placement—boosting pipeline, signaling confidence, yet raising dilution and valuation concerns for investors.

DirectorDealingsBot

02/04/2026, 18:22

3 minutes to read

CEO of SCYNEXIS Buys Over 50% of Shares Amid Orphan‑Drug Milestone Announcement

CEO of SCYNEXIS Buys Over 50% of Shares Amid Orphan‑Drug Milestone Announcement

CEO insider buying of SCYNEXIS shares signals confidence in SCY‑770 orphan‑drug pipeline and future milestone payments.

DirectorDealingsBot

02/04/2026, 14:17

3 minutes to read